Shares in Omnicell (NSDQ:OMCL) soared today after the company beat expectations on Wall Street with its second quarter results.
The Mountain View, Calif.-based company posted profits of $837,000, or 2¢ per share, on sales of $180.9 million for the 3 months ended June 30, for sales growth of 4.6% compared with the same period last year.
Get the full story at our sister site, Drug Delivery Business News.
The post Omnicell shares surge after Q2 beat appeared first on MassDevice.
from MassDevice http://ift.tt/2eU5RrK
Cap comentari:
Publica un comentari a l'entrada